Your Sorted CME/CE Activities

Thrombocytopenia in Chronic Liver Disease
Certified CME/CNE Activity - Mini Modules
Thrombocytopenia is a common manifestation among patients with chronic liver disease. In the setting of advanced liver disease, thrombocytopenia may negatively impact patient care by interfering with diagnostic and therapeutic procedures. The development of thrombopoietin agonists has the potential to provide clinicians with new options to improve patient care. However, current guidelines provide limited guidance on the optimal approach to increase platelet counts in patients with chronic liver disease.

These educational Mini Modules will outline the pathophysiologic mechanisms, platelet threshold levels, and other factors that impact the decision to initiate treatment for thrombocytopenia. In addition, the benefits and limitations of current and emerging therapeutic options will be discussed.
Review one (or all) Mini Modules of interest. Claim AMA or ANCC credit/contact hour(s) per module after completion of each brief Post-Test/Evaluation.
Fred Poordad, MD
Fred Poordad, MD
Professor of Medicine
UT Health San Antonio
Vice President
Academic and Clinical Affairs
Texas Liver Institute

Supported by an independent educational grant from Dova Pharmaceuticals
Expired Activity
Mini Module